Bernard L Kasten Net Worth

The estimated Net Worth of Bernard L Kasten is at least $571 Тысяча dollars as of 23 October 2014. Bernard Kasten owns over 15,900 units of SIGA Technologies Inc stock worth over $321,293 and over the last 20 years Bernard sold SIGA stock worth over $249,943.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Bernard Kasten SIGA stock SEC Form 4 insiders trading

Bernard has made over 5 trades of the SIGA Technologies Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Bernard sold 42,782 units of SIGA stock worth $171,556 on 6 January 2016.

The largest trade Bernard's ever made was buying 53,559 units of SIGA Technologies Inc stock on 11 October 2004 worth over $77,125. On average, Bernard trades about 5,370 units every 164 days since 2004. As of 23 October 2014 Bernard still owns at least 42,782 units of SIGA Technologies Inc stock.

You can see the complete history of Bernard Kasten stock trades at the bottom of the page.

What's Bernard Kasten's mailing address?

Bernard's mailing address filed with the SEC is 8622 TWILIGHT TEAR LANE, , CINCINNATI, OH, 45249.

Insiders trading at SIGA Technologies Inc

Over the last 21 years, insiders at SIGA Technologies Inc have traded over $65,185,125 worth of SIGA Technologies Inc stock and bought 6,065,626 units worth $33,817,674 . The most active insiders traders include Holdings Incperelman Ronald..., Pharma Inc Transtech и Adnan M M Mjalli. On average, SIGA Technologies Inc executives and independent directors trade stock every 36 days with the average trade being worth of $1,122,865. The most recent stock trade was executed by Dennis E Hruby on 1 July 2024, trading 32,258 units of SIGA stock currently worth $242,258.

What does SIGA Technologies Inc do?

at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.

Complete history of Bernard Kasten stock trades at Cytocom Inc, Enzo Biochem и SIGA Technologies Inc

SIGA Technologies Inc executives and stock owners

SIGA Technologies Inc executives and other stock owners filed with the SEC include:

• Daniel Luckshire,
  Chief Financial Officer, Executive Vice President, Secretary
• Dr. Phillip Louis Gomez III, M.D., Ph.D.,
  CEO & Director
• Phillip Gomez,
  Chief Executive Officer, Director
• Robin Abrams,
  Chief Administrative Officer, General Counsel
• Dr. Dennis E. Hruby,
  Exec. VP & Chief Scientific Officer
• Dennis Hruby,
  Chief Scientific Officer, Vice President
• Daniel J. Luckshire,
  Exec. VP, CFO & Sec.
• Robin E. Abrams,
  Gen. Counsel & Chief Admin. Officer
• Eric Rose,
  Chairman of the Board
• Julie Kane,
  Independent Director
• Michael Plansky,
  Independent Director
• Joseph Marshall,
  Independent Director
• James Antal,
  Independent Director
• Thomas Constance,
  Independent Director
• Herb Vloedman,
  Chief Information Officer
• Tove C. Bolken,
  Sr. VP of Operations & Chief Supply Chain Officer
• Diem Nguyen,
  Chief Executive Officer
• Larry R. Miller,
  General Counsel
• Holdings Incperelman Ronald...,
  
• Bruce Slovin,
  Director
• Paul G Savas,
  
• Jeffrey B Kindler,
  
• Scott M Hammer,
  Director
• Donald G Drapkin,
  Director
• Bernard L Kasten,
  Chief Executive Officer
• Ayelet Dugary,
  Acting Chief Financial Officer
• Judy S Slotkin,
  Director
• Michael Md Weiner,
  Director
• Thomas N Konatich,
  CFO, Secretary and Treasurer
• Adnan M M Mjalli,
  Director
• John Odden,
  VP - Business Development
• Ronald O Mac Andrews & Forb...,
  
• William C Bevins,
  Director
• Susan K Burgess,
  President
• Michael J Bayer,
  Director
• Frances F Townsend,
  Director
• William J Ii Haynes,
  Executive VP & General Counsel
• Steven L Fasman,
  Director
• Pharma Inc Transtech,
  10% owner
• & Forbes Holdings Inc.Perel...,
  
• Mehmet C Md Oz,
  Director
• Donald G Drapkin,
  Director
• Evan A. Knisely,
  
• Edward P. Taibi,
  
• Holly L. Phillips,
  
• Jaymie A Durnan,
  
• Gary J. Nabel,
  
• Julian Nemirovsky,
  
• Harold Eugene Jr. Ford,
  
• Jay Varma,
  EVP & Chief Medical Officer